Arrowhead Pharmaceuticals Inc (ARWR)
23.17
+0.55
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
23.13
-0.04
(-0.17%)
After-Hours: 20:00
Arrowhead Pharmaceuticals 1 Year Total Returns (Daily): -35.13% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -35.13% |
April 30, 2024 | -36.12% |
April 29, 2024 | -34.68% |
April 26, 2024 | -37.73% |
April 25, 2024 | -34.87% |
April 24, 2024 | -22.42% |
April 23, 2024 | -22.97% |
April 22, 2024 | -22.51% |
April 19, 2024 | -26.69% |
April 18, 2024 | -25.62% |
April 17, 2024 | -28.11% |
April 16, 2024 | -22.29% |
April 15, 2024 | -21.18% |
April 12, 2024 | -13.52% |
April 11, 2024 | -2.10% |
April 10, 2024 | -0.47% |
April 09, 2024 | 0.31% |
April 08, 2024 | -1.80% |
April 05, 2024 | 2.02% |
April 04, 2024 | 3.78% |
April 03, 2024 | 3.60% |
April 02, 2024 | 3.11% |
April 01, 2024 | 11.18% |
March 28, 2024 | 17.89% |
March 27, 2024 | 17.48% |
Date | Value |
---|---|
March 26, 2024 | 14.62% |
March 25, 2024 | 14.82% |
March 22, 2024 | 14.71% |
March 21, 2024 | 14.76% |
March 20, 2024 | 12.37% |
March 19, 2024 | 14.28% |
March 18, 2024 | 15.80% |
March 15, 2024 | 11.69% |
March 14, 2024 | 3.24% |
March 13, 2024 | 8.21% |
March 12, 2024 | 8.51% |
March 11, 2024 | 11.74% |
March 08, 2024 | 12.78% |
March 07, 2024 | 8.85% |
March 06, 2024 | 14.97% |
March 05, 2024 | 5.35% |
March 04, 2024 | 8.53% |
March 01, 2024 | 10.47% |
February 29, 2024 | -0.62% |
February 28, 2024 | 5.26% |
February 27, 2024 | -4.40% |
February 26, 2024 | -6.56% |
February 23, 2024 | -3.53% |
February 22, 2024 | -8.07% |
February 21, 2024 | -8.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.45%
Minimum
Jun 14 2022
501.1%
Maximum
Dec 24 2019
37.95%
Average
15.03%
Median
Dec 15 2020
1 Year Total Returns (Daily) Benchmarks
Madrigal Pharmaceuticals Inc | -32.10% |
Viking Therapeutics Inc | 245.5% |
Akero Therapeutics Inc | -55.31% |
89bio Inc | -47.38% |
Sagimet Biosciences Inc | -- |